Patents by Inventor Samir Attoub

Samir Attoub has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-DIABETIC STEROIDAL LACTONES OF WITHANIA COAGULANS FOR TREATMENT OF TYPE 2 DIABETES
    Publication number: 20250195599
    Abstract: Embodiments of the present disclosure include compositions and methods for treating type 2 diabetes using anti-diabetic steroidal lactones of Withania Coagulans, such as Coagulansin A and derivatives and analogues thereof are described. For example, a method of treating type 2 diabetes in a subject in need thereof, the method comprising administering a therapeutically effective amount of Coagulansin A or a derivative or analogue thereof to the subject is provided. Further described embodiments include compositions and methods of treating muscle atrophy in a subject with type 2 diabetes by initiating regeneration of diseased skeletal muscle myoblasts using anti-diabetic steroidal lactones of Withania Coagulans.
    Type: Application
    Filed: March 4, 2025
    Publication date: June 19, 2025
    Inventors: Abdu ADEM, Mariyam KHALID, Juma AL KAABI, Naheed AMIR, Samir ATTOUB
  • ANTI-DIABETIC STEROIDAL LACTONES OF WITHANIA COAGULANS FOR TREATMENT OF TYPE 2 DIABETES
    Publication number: 20230321175
    Abstract: Embodiments of the present disclosure include compositions and methods for treating type 2 diabetes using anti-diabetic steroidal lactones of Withania Coagulans, such as Coagulansin A and derivatives and analogues thereof are described. For example, a method of treating type 2 diabetes in a subject in need thereof, the method comprising administering a therapeutically effective amount of Coagulansin A or a derivative or analogue thereof to the subject is provided. Further described embodiments include compositions and methods of treating muscle atrophy in a subject with type 2 diabetes by initiating regeneration of diseased skeletal muscle myoblasts using anti-diabetic steroidal lactones of Withania Coagulans.
    Type: Application
    Filed: April 8, 2022
    Publication date: October 12, 2023
    Inventors: Abdu ADEM, Mariyam KHALID, Juma AL KAABI, Naheed AMIR, Samir ATTOUB
  • Thymoquinone derivatives for treatment of cancer
    Patent number: 10941128
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: March 9, 2021
    Assignee: United Arab Emirates University
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Thymoquinone derivatives for treatment of cancer
    Patent number: 10927088
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Grant
    Filed: October 10, 2019
    Date of Patent: February 23, 2021
    Assignee: United Arab Emirates University
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Thymoquinone Derivatives for Treatment of Cancer
    Publication number: 20200031789
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Application
    Filed: October 10, 2019
    Publication date: January 30, 2020
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Thymoquinone Derivatives for Treatment of Cancer
    Publication number: 20200031788
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Application
    Filed: October 10, 2019
    Publication date: January 30, 2020
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Thymoquinone derivatives for treatment of cancer
    Patent number: 10501428
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Grant
    Filed: August 9, 2014
    Date of Patent: December 10, 2019
    Assignee: United Arab Emirates University
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub
  • Thymoquinone Derivatives for Treatment of Cancer
    Publication number: 20170334871
    Abstract: The present invention describes thymoquinone compounds formula (I): (i) These compounds have been identified as being useful in the treatment of cancer.
    Type: Application
    Filed: August 9, 2014
    Publication date: November 23, 2017
    Inventors: Alaa Eldin Salem, Ismail El Haty, Ibrahim Abdou, Abdu Adem, Samir Attoub